UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Announcement of Invossa license revocation was ‘procedural breach’: Kolon
The government’s recent announcement that it would nullify the license of I...
by Jeong Sae-im
|
2019-05-30 13:28
라인
HIV prevention pill to get insurance benefit in Korea
The local medical community is likely to use a drug to prevent HIV infectio...
by Kim Yun-mi
|
2019-05-30 13:25
라인
Psychiatrists frustrated over alleged sexual predator’s continued medical practice
The Korea NeuroPsychiatric Association (KNPA) expressed resentment over the...
by Song Soo-youn
|
2019-05-29 17:17
라인
JW Medical to launch Hitachi's ultrasound scanner device
JW Medical, a subsidiary of JW Holdings, said Tuesday that it has begun to ...
by Lee Han-soo
|
2019-05-29 17:06
라인
Daiichi Sankyo to co-promote Daewoong's hypertension treatment
Daiichi Sankyo Korea has signed an agreement with Daewoong to co-promote Ol...
by Lee Han-soo
|
2019-05-29 14:50
라인
Regulator faces serious repercussions after Invossa debacle
The Ministry of Food and Drug Safety recently confirmed that Kolon Life Sci...
by Lee Hye-seon
|
2019-05-29 14:50
라인
‘MDM2 gene’ may be associated with hyperprogression after immunotherapy
Oncology researchers around the world are paying keen attention to MDM2 (mo...
by Kim Yun-mi
|
2019-05-29 12:35
라인
YUHS transfer metastatic anticancer drug candidate technology to Repure Life Science
Yonsei University Medical Center has transferred its metastatic cancer chem...
by Lee Han-soo
|
2019-05-28 16:28
라인
Invossa poses almost no safety threat: regulator
The Ministry of Food and Drug Safety said there was no significant concern ...
by Lee Hye-seon
|
2019-05-28 16:02
라인
Government to discuss gaming disorder for disease classification
As the World Health Organization recently decided to classify gaming disord...
by Kwak Sung-sun
|
2019-05-28 14:44
라인
‘Enstilum treats all psoriasis from mild to severe ones’
Enstilum Foam (betamethasone dipropionate/calcipotriol), a foam-type treatm...
by Kim Yun-mi
|
2019-05-28 14:44
라인
Indonesia gave nods to Medytox's hyaluronic acid filler
Medytox said Tuesday that it has received sales approval for its Neuramis l...
by Lee Han-soo
|
2019-05-28 14:42
라인
Reimbursements at Big 5 hospitals surged 26% in 2018
The state health insurance agency paid nearly 4 trillion won ($3.37 billion...
by Song Soo-youn
|
2019-05-28 11:34
라인
Seoul revokes sales license of Invossa-K, prosecutes Kolon Life Science
The Ministry of Food and Drug Safety has revoked the sales approval for Kol...
by Lee Han-soo
|
2019-05-28 11:31
라인
Corestem applies for FDA meet on Lou Gehrig's drug
Corestem said Monday that it has applied for a pre-investigational new drug...
by Lee Han-soo
|
2019-05-27 17:51
라인
‘4 Oriental medical students sexually harassed women on mobile group chat’
Four students at Daejeon University’s College of Oriental Medicine sexually...
by Choi Gwang-seok
|
2019-05-27 15:56
라인
Brazil OKs Samsung Bioepis’ trastuzumab biosimilar
Brazil’s Agencia Nacional de Vigilancia Sanitaria has granted marketing aut...
by Lee Han-soo
|
2019-05-27 15:52
라인
Medytox suspected of GMP violation filed at anti-corruption commission
Medytox, the Korean botulinum toxin maker, is suspected of breaching Good M...
by Jeong Sae-im
|
2019-05-27 15:52
라인
[Pre-ASCO 2019] Yooyoung Pharmaceutical: YYB101 -- refractory solid tumor treatment
Yooyoung Pharmaceutical will present the results of its phase 1 clinical tr...
by Lee Han-soo
|
2019-05-27 14:22
라인
‘Patient Revolution’ author had chiropractor license revoked in US
Joshua Cho, the author of the popular healthcare book “Patient Revolution,”...
by Song Soo-youn
|
2019-05-27 12:16
-
이전
121
122
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top